WP6. Proof of concept

i) to test phage therapy on microbial communities containing ARB in well-controlled bioreactors at wet lab; ii) to develop a pilot scale passive treatment system (i.e., constructed wetland) and test the phage-based biotechnology developed for the removal of ARB/ARGs under real operation conditions; iii) to up-scale the CW technology with calculation of its cost effectiveness and operational capacity; and iv) to evaluate the long-term effect of phages on CW functioning as well as the structure of the microbiome and resistome of CWs.